News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
625,833 Results
Type
Article (61554)
Company Profile (109)
Press Release (564158)
Multimedia
Podcasts (139)
Webinars (26)
Section
Business (171285)
Career Advice (2265)
Deals (25929)
Drug Delivery (109)
Drug Development (71293)
Employer Resources (150)
FDA (15898)
Job Trends (13015)
News (292205)
Policy (30417)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (2961)
Academic (2)
Accelerated approval (39)
Adcomms (23)
Allergies (175)
Alliances (46695)
ALS (186)
Alzheimer's disease (1718)
Antibody-drug conjugate (ADC) (369)
Approvals (16253)
Artificial intelligence (619)
Autoimmune disease (227)
Automation (46)
Bankruptcy (227)
Best Places to Work (10196)
BIOSECURE Act (15)
Biosimilars (164)
Biotechnology (77)
Bladder cancer (159)
Brain cancer (66)
Breast cancer (652)
Cancer (5130)
Cardiovascular disease (403)
Career advice (1933)
Career pathing (39)
CAR-T (282)
CDC (46)
Celiac Disease (1)
Cell therapy (768)
Cervical cancer (40)
Clinical research (60819)
Collaboration (1951)
Company closure (2)
Compensation (499)
Complete response letters (66)
COVID-19 (2698)
CRISPR (95)
C-suite (864)
Cystic fibrosis (140)
Data (6842)
Decentralized trials (3)
Denatured (50)
Depression (148)
Dermatology (60)
Diabetes (503)
Diagnostics (5878)
Digital health (45)
Diversity (9)
Diversity, equity & inclusion (40)
Drug discovery (314)
Drug pricing (151)
Drug shortages (24)
Duchenne muscular dystrophy (247)
Earnings (73114)
Editorial (65)
Employer branding (20)
Employer resources (135)
Events (88098)
Executive appointments (895)
FDA (19440)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (30)
Funding (1452)
Gene editing (197)
Generative AI (60)
Gene therapy (622)
GLP-1 (916)
Government (4567)
Grass and pollen (8)
Guidances (389)
Healthcare (16347)
HIV (68)
Huntington's disease (44)
IgA nephropathy (76)
Immunology and inflammation (207)
Immuno-oncology (77)
Indications (154)
Infectious disease (2990)
Inflammatory bowel disease (180)
Inflation Reduction Act (15)
Influenza (118)
Intellectual property (240)
Interviews (414)
IPO (11921)
IRA (50)
Job creations (3124)
Job search strategy (1602)
JPM (56)
Kidney cancer (13)
Labor market (81)
Layoffs (456)
Leadership (35)
Legal (6323)
Liver cancer (86)
Longevity (27)
Lung cancer (670)
Lymphoma (387)
Machine learning (52)
Management (50)
Manufacturing (817)
MASH (169)
Medical device (10849)
Medtech (10912)
Mergers & acquisitions (15013)
Metabolic disorders (1237)
mRNA (189)
Multiple sclerosis (161)
NASH (14)
Neurodegenerative disease (360)
Neuropsychiatric disorders (83)
Neuroscience (3037)
Neurotech (1)
NextGen: Class of 2026 (5545)
Non-profit (4687)
Now hiring (57)
Obesity (536)
Opinion (291)
Ovarian cancer (198)
Pain (213)
Pancreatic cancer (246)
Parkinson's disease (334)
Partnered (34)
Patents (468)
Patient recruitment (530)
Peanut (66)
People (48632)
Pharmaceutical (24)
Pharmacy benefit managers (20)
Phase 1 (18513)
Phase 2 (26038)
Phase 3 (20950)
Pipeline (7147)
Policy (286)
Postmarket research (2714)
Preclinical (8835)
Press Release (69)
Prostate cancer (284)
Psychedelics (45)
Radiopharmaceuticals (279)
Rare diseases (933)
Real estate (5125)
Recruiting (63)
Regulatory (24421)
Reports (43)
Research institute (2683)
Resumes & cover letters (357)
Rett syndrome (32)
RNA editing (16)
RSV (74)
Schizophrenia (158)
Series A (231)
Series B (155)
Service/supplier (12)
Sickle cell disease (99)
Special edition (26)
Spinal muscular atrophy (167)
Sponsored (44)
Startups (2911)
State (1)
Stomach cancer (12)
Supply chain (94)
Tariffs (59)
The Weekly (88)
Vaccines (1040)
Venture capital (76)
Weight loss (329)
Women's health (101)
Worklife (20)
Date
Today (39)
Last 7 days (641)
Last 30 days (2297)
Last 365 days (25950)
2026 (8471)
2025 (25986)
2024 (29532)
2023 (33721)
2022 (44607)
2021 (48020)
2020 (46557)
2019 (40735)
2018 (30933)
2017 (28437)
2016 (28231)
2015 (32909)
2014 (26987)
2013 (24098)
2012 (24437)
2011 (24479)
2010 (23170)
Location
Africa (889)
Alabama (92)
Alaska (6)
Arizona (258)
Arkansas (12)
Asia (37349)
Australia (6723)
California (10202)
Canada (3084)
China (1157)
Colorado (469)
Connecticut (486)
Delaware (317)
Europe (87081)
Florida (1659)
Georgia (356)
Hawaii (2)
Idaho (46)
Illinois (860)
India (81)
Indiana (514)
Iowa (23)
Japan (477)
Kansas (114)
Kentucky (39)
Louisiana (31)
Maine (42)
Maryland (1320)
Massachusetts (7321)
Michigan (338)
Minnesota (517)
Mississippi (5)
Missouri (120)
Montana (23)
Nebraska (25)
Nevada (110)
New Hampshire (71)
New Jersey (3054)
New Mexico (31)
New York (2880)
North Carolina (1489)
North Dakota (7)
Northern California (4988)
Ohio (298)
Oklahoma (21)
Oregon (31)
Pennsylvania (2062)
Puerto Rico (21)
Rhode Island (44)
South America (1156)
South Carolina (54)
South Dakota (1)
Southern California (4123)
Tennessee (180)
Texas (1636)
United States (37398)
Utah (329)
Vermont (1)
Virginia (267)
Washington D.C. (72)
Washington State (893)
West Virginia (3)
Wisconsin (116)
Wyoming (2)
625,833 Results for "food allergy research and education".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Venture capital
After Exiting 2seventy, Chip Baird Took a 180 to Food Allergy With Newly Launched Poplar
Poplar Therapeutics is seeking a “step change” in the treatment of food allergy and other atopic conditions, with $95 million raised to date, including a $45 million series A extension that closed Tuesday.
March 3, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Restart Life Announces Collaboration with University of Manitoba’s Centre for Food Technology and Research
March 3, 2026
·
1 min read
Press Releases
Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science
February 5, 2026
·
2 min read
Mergers & acquisitions
Novartis Keeps Deals Coming With $2B Excellergy Takeover
The Excellergy acquisition will complement Novartis’ existing allergy profile, anchored by the IgE blocker Xolair that in February 2024 was approved to treat food allergies in children and adults.
March 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Restart Life Announces Food Technology and Research Studies
December 17, 2025
·
6 min read
Press Releases
HSS Presents New Research Leveraging AI to Uncover Insights Related to Pain Risk and Anesthesia Education at ASRA Annual Meeting
April 20, 2026
·
9 min read
Immunology and inflammation
First Head-to-Head Study Cements Roche’s Xolair as Food Allergy Leader
Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children with one or more food allergies.
March 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
NEW SINGAPORE STUDY TO ASSESS GROWING PREVALENCE AND IMPACT OF FOOD ALLERGIES
June 27, 2025
·
13 min read
Press Releases
RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies
October 28, 2025
·
7 min read
Press Releases
The future of allergy treatment
February 24, 2026
·
1 min read
1 of 62,584
Next
